Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma

被引:34
作者
Jamroziak, Krzysztof [1 ]
Balcerczak, Ewa [2 ]
Calka, Karolina [2 ]
Piaskowski, Sylwester [3 ]
Urbanska-Rys, Halina [1 ]
Salagacka, Aleksandra [2 ]
Mirowski, Marek [2 ]
Robak, Tadeusz [1 ]
机构
[1] Med Univ Lodz, Dept Hematol, PL-93513 Lodz, Poland
[2] Med Univ Lodz, Lab Mol Biol & Pharmacogenom, Dept Pharmaceut Biochem, Lodz, Poland
[3] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland
关键词
P-glycoprotein; MDR1; ABCB1; SNP; Haplotype; Multiple myeloma; Genetic predisposition; MDR1; GENE; SUSCEPTIBILITY;
D O I
10.1016/j.leukres.2008.06.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDR1(ABCB1) gene encodes Cor P-glycoprotein (P-gp, MDR1, ABCB1), an ATP-binding cassette superfamily member involved in the transport of xenobiotics. Here, we investigated whether common MDR1 single nucleotide polymorphisms (1236C>T, 2677G>A/T and 3435C>T) affect predisposition to multiple myeloma. Genotyping was performed in 111 myeloma patients and 96 controls by PCR-based assays. Haplotypes were inferred Using PHASE algorithm. We found comparable allele and genotype frequencies among myeloma patients and controls. Moreover, patient and control groups did not differ regarding MDR1 haplotype distribution (p = 0.18). In conclusion, our results do not support major influence of MDR1 variants oil the risk of myeloma in Caucasians. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:332 / 335
页数:4
相关论文
共 8 条
[1]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[2]   Functional C3435T polymorphism of MDR1 gene:: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia [J].
Jamroziak, K ;
Mlynarski, W ;
Balcerczak, E ;
Mistygacz, M ;
Trelinska, J ;
Mirowski, M ;
Bodalski, J ;
Robak, T .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (05) :314-321
[3]   A "silent" polymorphism in the MDR1 gene changes substrate specificity [J].
Kimchi-Sarfaty, Chava ;
Oh, Jung Mi ;
Kim, In-Wha ;
Sauna, Zuben E. ;
Calcagno, Anna Maria ;
Ambudkar, Suresh V. ;
Gottesman, Michael M. .
SCIENCE, 2007, 315 (5811) :525-528
[4]   Epidemiology of the plasma-cell disorders [J].
Kyle, Robert A. ;
Rajkurnar, S. Vincent .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) :637-664
[5]   MDR1 diplotypes as prognostic markers in multiple myeloma [J].
Maggini, Valentina ;
Buda, Gabriele ;
Martino, Alessandro ;
Presciuttini, Silvano ;
Galimberti, Sara ;
Orciuolo, Enrico ;
Barale, Roberto ;
Petrini, Mario ;
Rossi, Anna Maria .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (05) :383-389
[6]  
Sakaeda Toshiyuki, 2005, Drug Metab Pharmacokinet, V20, P391, DOI 10.2133/dmpk.20.391
[7]   Association of the P-glycoprotein transporter MDR1C3435T polymorphism with the susceptibility to renal epithelial tumors [J].
Siegsmund, M ;
Brinkmann, U ;
Schäffeler, E ;
Weirich, G ;
Schwab, M ;
Eichelbaum, M ;
Fritz, P ;
Burk, O ;
Decker, J ;
Alken, P ;
Rothenpieler, U ;
Kerb, R ;
Hoffmeyer, S ;
Brauch, H .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1847-1854
[8]   A new statistical method for haplotype reconstruction from population data [J].
Stephens, M ;
Smith, NJ ;
Donnelly, P .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (04) :978-989